RESUMO
To clarify the physiological role of placental corticotropin-releasing hormone (CRH), we measured plasma CRH, ACTH, and cortisol throughout pregnancy. Cerebrospinal fluid (CSF) CRH levels and ACTH responsiveness to synthetic CRH were also quantified in pregnant and nonpregnant women. Maternal plasma CRH levels, which increased progressively during pregnancy, correlated well with both ACTH and cortisol in early labor, delivery, and postpartum samples, and also with cortisol levels in samples before labor. CSF CRH levels in term pregnant women did not differ from those of nonpregnant women. CRH infusion that attained similar plasma CRH levels to those found in late pregnancy elicited significant ACTH release in vivo and regular CRH test provoked normal ACTH response during early pregnancy but no response during late pregnancy. We concluded that: (a) maternal pituitary-adrenal axis correlates well with plasma CRH levels, which are high enough to provoke ACTH release from maternal pituitary; (b) hypothalamic CRH secretion in term pregnant women is not exaggerated; and (c) maternal pituitary is responsive to synthetic CRH in early but not late pregnancy, suggesting that maternal pituitary-adrenal axis is already activated by high circulating CRH. Placental CRH may be an important stimulator of the maternal pituitary-adrenal axis during pregnancy.
Assuntos
Hormônio Adrenocorticotrópico/metabolismo , Hormônio Liberador da Corticotropina/fisiologia , Hipófise/metabolismo , Placenta/fisiologia , Hormônio Adrenocorticotrópico/sangue , Adulto , Hormônio Liberador da Corticotropina/sangue , Feminino , Humanos , Hidrocortisona/sangue , Trabalho de Parto/sangue , Período Pós-Parto/sangue , GravidezRESUMO
We measured FSH and LH concentrations by RIA in 130 cord sera and 213 peripheral sera obtained as serially as possible from 67 infants who were 5-75 days old and were born between the 28th and 42nd gestational weeks. Cord serum FSH and LH (+hCG) levels were 3.9-13.6 mIU/ml and 43.3-88.6 mIU/ml, respectively; they decreased with advancing gestational age. Postnatal FSH levels in male infants maintained low levels (3.7-8.7 mIU/ml). However, those in female infants increased with peak levels (51.8-270.3 mIU/ml) between 11 and 30 days after delivery, and then decreased; the surge was more marked and prolonged in preterm infants than in term infants. Postnatal LH levels in both sexes decreased rapidly after birth, which may be due to a decrease of placental hCG, and thereafter displayed patterns similar to FSH levels. We found a significant sex difference of serum gonadotropin levels in newborn infants and differences between term and preterm infants. Our results suggest that the sex difference of pituitary gonadal function exists and that the function matures during the fetal and neonatal life.
Assuntos
Gonadotropina Coriônica/sangue , Hormônio Foliculoestimulante/sangue , Recém-Nascido Prematuro , Hormônio Luteinizante/sangue , Feminino , Sangue Fetal , Idade Gestacional , Humanos , Recém-Nascido , MasculinoRESUMO
Peptide histidine isoleucine (PHI) was initially isolated from the porcine gastrointestinal tract and may be present in the brain. It has been suggested that PHI may be PRL-releasing hormone (PRH) because of its potent PRL-releasing activity and its existence in hypophysial portal plasma in rats. Vasoactive intestinal peptide and PHI are coded by the same gene, and human PHI has a C-terminal methionine instead of isoleucine [peptide histidine methionine (PHM)]. To investigate the possibility that PHM is a physiological PRH in humans, we measured the immunoreactive PHM concentration in human hypothalamic tissue and cerebrospinal fluid (CSF) using a specific RIA. We also examined in vivo the PRH activity of synthetic PHM. The human hypothalamus contained 19.3 +/- 6.2 (+/- SD; n = 5) pmol/hypothalamus, very similar to the content of GHRH or CRH. Immunoreactive PHM was also present in CSF; its levels in CSF were significantly lower in patients with prolactinomas than in control subjects. The CSF PHM levels in such patients increased after correction of hyperprolactinemia by long term bromocriptine therapy. The CSF PHM levels also were low in pregnant women. There was a significant negative correlation between plasma PRL and CSF PHM levels in all of these subjects. Gel filtration profiles of CSF extracts from normal subjects revealed two peaks of immunoreactive PHM: a high mol wt peak and one at the elution position of synthetic PHM. This profile resembled that of hyppothalamic extract. In contrast, only high mol wt material was detected in CSF from hyperprolactinemic subjects. Intravenous administration of synthetic PHM elicited a significant increase in plasma PRL in normal subjects; the responses to PHM were higher in women than in men. The presence of large amounts of immunoreactive PHM in the human hypothalamus suggests that PHM may participate in the regulation of anterior pituitary hormone secretion. Its specific PRL-releasing activity in vivo and the low CSF PHM levels of hyperprolactinemic subjects suggest that PHM may be a physiological PRH in humans.
Assuntos
Peptídeo PHI/fisiologia , Hormônio Liberador de Tireotropina/fisiologia , Idoso , Cromatografia em Gel , Hormônio Liberador da Corticotropina/análise , Feminino , Hormônio Liberador de Hormônio do Crescimento/análise , Humanos , Hipotálamo/análise , Masculino , Pessoa de Meia-Idade , Peptídeo PHI/análise , Peptídeo PHI/farmacologia , Prolactina/metabolismo , RadioimunoensaioRESUMO
Immunoreactive CRH was detected in extracts of human term placentae [5.2 +/- 0.8 (+/- SE) pmol/g wet wt; n = 9]. Molecular sieve chromatography revealed three size classes of immunoreactive CRH. The major species eluted with the Kav of synthetic rat CRH; the minor species had apparent mol wt (MW) of 18,000 and 8,000. A placental CRH-(1-41)-sized peptide was isolated by fractional acetone precipitation, molecular sieve chromatography, and sequential reverse phase high performance liquid chromatography steps. This peptide had the same chromatographic behavior as did rat CRH in all high performance liquid chromatographic isolation steps as well as the same UV absorbance to immunoreactive CRH ratio after the final purification step. Purified placental CRH stimulated ACTH release from anterior pituitary tissue in a dose-dependent manner and was equipotent with synthetic rat CRH. Partial sequencing indicated that 32 amino acids of this peptide are identical to those of rat and human CRH (sequence deduced from genomic sequence), and comparative peptide mapping with rat CRH provided further evidence that the placental CRH-like peptide is very homologous if not identical to CRH. The high mol wt placental CRH fractions also were partially purified by acetone precipitation, immune affinity chromatography, and gel filtration. Neither of these materials [big form (MW, 18,000) or intermediate form (MWr, 8,000)] stimulated ACTH release from rat pituitary tissue in vitro. Limited trypsin digestion of the highest MW CRH, followed by gel filtration analysis, resulted in conversion to the smaller [8,000 MW-sized and CRH-(1-41)-sized] forms. The detection of a CRH-like peptide in placenta together with our previous demonstration of plasma immunoreactive CRH in pregnant women suggest that the placenta synthesizes and secretes CRH into the maternal circulation.
Assuntos
Hormônio Liberador da Corticotropina/isolamento & purificação , Peptídeos/isolamento & purificação , Placenta/análise , Sequência de Aminoácidos , Cromatografia em Gel , Cromatografia Líquida de Alta Pressão , Hormônio Liberador da Corticotropina/fisiologia , Feminino , Humanos , Hidrólise , Dados de Sequência Molecular , Mapeamento de Peptídeos , Gravidez , Radioimunoensaio , TripsinaRESUMO
We previously reported that immunoreactive corticotropin-releasing hormone (CRH) is present in human placenta and third trimester maternal plasma, and that such material is very similar to rat CRH and the predicted structure of human CRH. We suggested that maternal plasma immunoreactive CRH may be of placental origin. To further investigate this possibility, we measured plasma immunoreactive CRH in women during pregnancy, labor, and delivery and 1 and 2 h postpartum, and in nonpregnant women. Umbilical cord plasma and placental CRH concentrations were also measured. In the first trimester of pregnancy, the mean maternal plasma level was 5.9 +/- 1.0 pg (+/- SEM)/ml (n = 24), not significantly different from that in 10 nonpregnant women (5.8 +/- 0.8 pg/ml). Plasma CRH concentrations progressively increased during pregnancy (second trimester, 35.4 +/- 5.9 pg/ml (n = 39); early third trimester (28-34 weeks), 263 +/- 41 pg/ml (n = 14); late third trimester (35-40 weeks), 800 +/- 163 pg/ml (n = 20)]. There was a significant correlation between maternal plasma CRH levels and weeks of pregnancy. Plasma CRH concentrations were further elevated (2215 +/- 329 pg/ml; n = 9). During early labor, peaked at delivery (4409 +/- 591 pg/ml; n = 28), and declined rapidly after delivery [1 h postpartum, 1042 +/- (353 pg/ml (n = 13); 2 h postpartum, 346 +/- 91 pg/ml (n = 13)]. There was a significant correlation (r = 0.562; P less than 0.01) between matched maternal plasma and placental CRH concentrations. The mean umbilical cord plasma CRH level (50.6 +/- 6.1 pg/ml; n = 28) was much lower than that in the mother at the time of delivery. Umbilical venous plasma CRH levels were significantly greater than those in simultaneously obtained umbilical arterial plasma (70.8 +/- 11.3 and 41.8 +/- 4.9 pg/ml, respectively; n = 11). There was a significant correlation (r = 0.384; P less than 0.05) between maternal and fetal CRH concentrations. Gel filtration of plasma obtained from women during the third trimester, at delivery, and early postpartum and placental extracts revealed two major peaks of immunoreactive CRH: a high mol wt peak and one at the elution position of rat CRH. In contrast, only rat CRH-sized material was detected in plasma from nonpregnant women and umbilical cord plasma. Maternal plasma immunoreactive CRH-sized material stimulated ACTH release from anterior pituitary tissue in a dose-dependent manner and was equipotent with rat CRH.(ABSTRACT TRUNCATED AT 400 WORDS)
Assuntos
Hormônio Liberador da Corticotropina/sangue , Trabalho de Parto/sangue , Gravidez/sangue , Adolescente , Adulto , Bioensaio , Cromatografia de Afinidade , Cromatografia em Gel , Feminino , Sangue Fetal/análise , Humanos , Recém-Nascido , Placenta/metabolismo , RadioimunoensaioRESUMO
Production of rT3 from T4 in the placenta were measured in four patients with induced abortion, in three patients with spontaneous abortion, in 19 patients with various complications of pregnancy including Graves' disease, and in 18 normal pregnancies. The placentas, obtained at delivery, were homogenized and centrifuged at 800 X g. Supernatants (1 mg protein) were incubated with 1 microgram of stable T4 and 50 mmol/L dithiothreitol at 37 degrees C for 60 minutes. The generated rT3 was measured by radioimmunoassay (RIA). In patients who delivered at 38 to 41 weeks with complicated pregnancy, the net placental rT3 production from T4 was 7.3 +/- 2.5 ng/tube, which was not significantly different from that obtained in normal pregnancy (8.5 +/- 2.4) at an equivalent gestational age. In patients with abortions, the net placental rT3 generation from T4 was very high, and there was a significant negative correlation between the net placental rT3 production from T4 and gestational age. These results indicate that the net placental rT3 production from T4 is not affected by complications of pregnancy, but shows a significant change with the progress of gestation.
Assuntos
Placenta/enzimologia , Complicações na Gravidez/enzimologia , Aborto Induzido , Aborto Espontâneo/enzimologia , Líquido Amniótico/análise , Feminino , Sangue Fetal/análise , Idade Gestacional , Humanos , Recém-Nascido , Iodeto Peroxidase/metabolismo , Gravidez , Tri-Iodotironina Reversa/sangue , Tri-Iodotironina Reversa/metabolismoRESUMO
OBJECTIVES: To clarify the relationship between hydrops fetalis and parvovirus outbreaks in the community, seroprevalence of B19 antibody among women of childbearing age, and adverse effects of intrauterine B19 infection. METHODS: Sera were collected from 168 cases of hydrops fetalis which were diagnosed between 1987 and 1997 in Miyagi prefecture, Japan, from 232 healthy pregnant women in 1987 and 277 healthy pregnant women in 1997 in Miyagi, and from 48 women infected with B19 during pregnancy. The sera were examined for B19 IgG and IgM antibodies by enzyme-linked immunosorbent assay and for B19 DNA by polymerase chain reaction. The number of cases of erythema infectiosum in Miyagi had been monitored each month. RESULTS: Thirteen of the 168 cases of hydrops fetalis were found to be caused by intrauterine B19 infection and 12 of the 13 cases clustered in two periods of outbreaks of erythema infectiosum in the community. The positive rates of B19 IgG antibody between 1987 and 1997 were significantly different: 33% in 1987 and 46% in 1997. Nine of the 48 women infected during pregnancy showed adverse effects of the fetus: eight hydrops fetalis and one early abortion with positive B19 DNA. The fetal death rate (>12 weeks of gestation) among them was 15% (7/48), far higher than the calculated 1% among the general population. The nine mothers with adverse fetal outcomes had contact with the infectious source at the 16 weeks of gestation or earlier. CONCLUSIONS: These data clearly showed a relationship between hydrops fetalis and parvovirus outbreaks in the community, and it may be important to follow the seroprevalence for an extrapolated period time to predict occurrence of hydrops fetalis caused by B19. Also the data indicated that the gestational week infection occurred is the most important determinant of an adverse effect to the fetus as described previously.
Assuntos
Infecções por Parvoviridae/diagnóstico , Parvovirus B19 Humano/isolamento & purificação , Complicações Infecciosas na Gravidez/virologia , Adolescente , Adulto , Anticorpos Antivirais/sangue , DNA Viral/sangue , Feminino , Humanos , Hidropisia Fetal/diagnóstico , Hidropisia Fetal/epidemiologia , Hidropisia Fetal/virologia , Infecções por Parvoviridae/epidemiologia , Parvovirus B19 Humano/imunologia , Gravidez , Complicações Infecciosas na Gravidez/sangue , Complicações Infecciosas na Gravidez/epidemiologia , Estudos Prospectivos , Estudos SoroepidemiológicosRESUMO
Immunoreactive corticotropin-releasing hormone in the amniotic fluid of both human beings and rats was measured by a specific radioimmunoassay. In human subjects the hormone was detectable in all amniotic fluid samples (obtained during the sixteenth and eighteenth weeks of gestation) (2.5 +/- 1.7 fmol/ml, mean +/- SD, n = 17) and the thirty-eighth to fortieth weeks (9.3 +/- 5.4 fmol/ml, n = 24). The levels of concentration of this hormone in this amniotic fluid correlated significantly with the levels in both maternal plasma and placenta for each patient. Gel filtration of amniotic fluid extracts revealed two major peaks of immunoreactive corticotropin-releasing hormone, one at the elution position of the rat hormone and the other at a small-molecular-weight region. Immunoreactive corticotropin-releasing hormone was not detectable in rat amniotic fluid or placenta. We concluded that immunoreactive corticotropin-releasing hormone, which may be derived from the placenta, is present in human amniotic fluid and that its detection in the human placenta but not in rat placentas suggests that the mechanism of corticotropin-releasing hormone gene expression in the placenta is species specific.
Assuntos
Líquido Amniótico/metabolismo , Hormônio Liberador da Corticotropina/metabolismo , Adolescente , Adulto , Animais , Feminino , Humanos , Concentração Osmolar , Placenta/metabolismo , Radioimunoensaio , Ratos , Ratos EndogâmicosRESUMO
In this study, we measured cord serum thyroxine (T4), triiodothyronine (T3), reverse T3 (rT3), thyroxine binding globulin (TBG) and thyroid-stimulating hormone (TSH) in 37 fetuses (29-42 gestational weeks). The mean cord serum TBG was 18.2 +/- 3.2 mg/dl (mean +/- S.E., n = 37) and there was no correlation between cord serum TBG levels and gestational weeks. The cord serum T3 levels increased with advancing gestational weeks. On the other hand, cord serum rT3 levels decreased with advancing gestational weeks. There was a significant positive correlation between the TBG and T4 levels after 32 gestational weeks (n = 34, r = 0.545, p less than 0.001), and between the TBG and T3 levels (n = 36, r = 0.65, p less than 0.001). There was a significant positive correlation between the TBG and T3 levels after 37 gestational weeks (n = 24, r = 0.43, p less than 0.05). The cord serum TSH levels had a significant difference (p less than 0.05) between preterm fetus (n = 11, 12.8 +/- 2.2 mU/ml, mean +/- S.E.) and term fetus (n = 25, 8.2 +/- 0.8 mU/ml). The T4/TSH ratio in the preterm fetus (0.65 +/- 0.01) was significantly smaller (p less than 0.001) than that of term fetus (1.60 +/- 0.16). These results suggest that thyroid hormones are closely related with TBG in fetus and the sensitivity of the thyroid gland to TSH may increase with advancing gestational weeks.
Assuntos
alfa-Globulinas/análise , Sangue Fetal/análise , Hormônios Tireóideos/sangue , Proteínas de Ligação a Tiroxina/análise , Feminino , Idade Gestacional , Humanos , Gravidez , Tireotropina/sangue , Tiroxina/sangue , Tri-Iodotironina/sangue , Tri-Iodotironina Reversa/sangueRESUMO
A case of cephalothoracopagus syncephalus conjoined twins was diagnosed by pre-natal amniography. Hormone levels in maternal blood, umbilical blood and amniotic fluid were measured.
Assuntos
Anormalidades Teratoides Graves/diagnóstico , Hormônio do Crescimento , Diagnóstico Pré-Natal , Âmnio , Líquido Amniótico/análise , Feminino , Hormônio Foliculoestimulante/análise , Hormônio Foliculoestimulante/sangue , Hormônio do Crescimento/análise , Hormônio do Crescimento/sangue , Humanos , Recém-Nascido , Hormônio Luteinizante/análise , Hormônio Luteinizante/sangue , Gravidez , Prolactina/análise , Prolactina/sangue , Tireotropina/análise , Tireotropina/sangueRESUMO
The pituitary endocrine function in 4 anencephalic infants was studied by measuring the concentrations of growth hormone, prolactin, thyroid-stimulating hormone (TSH), follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in umbilical venous serum. There was no significant difference in hormone levels between the anencephalic and normal infants. The response of FSH and LH was negative after administration of 10 micrograms of luteinizing hormone-releasing hormone. The TSH levels after administration of 50 micrograms of TRH elevated about 4- to 6-fold over pre-administration levels. These results indicate that the hypothalamo-pituitary axis of the human fetus initiates its function from mid-pregnancy; TSH may have an autoregulating system of the pituitary itself.
Assuntos
Anencefalia/fisiopatologia , Hipófise/fisiopatologia , Hormônios Hipofisários/sangue , Feminino , Hormônio Foliculoestimulante/sangue , Hormônio Liberador de Gonadotropina/farmacologia , Hormônio do Crescimento/sangue , Humanos , Hipotálamo/fisiopatologia , Recém-Nascido , Hormônio Luteinizante/sangue , Testes de Função Hipofisária , Gravidez , Prolactina/sangue , Tireotropina/sangue , Hormônio Liberador de Tireotropina/farmacologiaRESUMO
RT3(3,3',5'-triiodothyronine) levels in amniotic fluid and T4(thyroxine), T3(triiodothyronine), rT3 and TSH(thyroid-stimulating hormone) levels in maternal and cord serum were determined simultaneously by RIA. We also determined the activities of the monodeiodination of thyroxine to rT3 in placentas. Amniotic fluid rT3 and cord serum rT3 levels decreased, but T4, T3 and TSH levels increased with advancing gestational age. The activities of the monodeiodination in placentas decreased rapidly from midgestation, preterm to term. In maternal hyperthyroidism, amniotic fluid rT3 levels were markedly elevated. Moreover, there were significant positive correlations between amniotic fluid rT3 and maternal serum rT3 (r = 0.756, p less than 0.001, n = 26) and T4(r = 0.509, p less than 0.01, n = 26) in the normal 3rd trimester. We found significant correlations between amniotic fluid rT3 and fetal thyroid function as well as the activity of the monodeiodination in placenta after 17 weeks' gestation. But we couldn't find any such correlations in the 3rd trimester. These data suggest that the amniotic fluid rT3 in the 3rd trimester was affected by maternal thyroid function as well as fetal thyroid function and the activity of the monodeiodination in placenta.
Assuntos
Líquido Amniótico/análise , Tri-Iodotironina Reversa/análise , Feminino , Sangue Fetal/análise , Doenças Fetais/diagnóstico , Idade Gestacional , Humanos , Recém-Nascido , Troca Materno-Fetal , Gravidez , Complicações na Gravidez/metabolismo , Doenças da Glândula Tireoide/diagnóstico , Doenças da Glândula Tireoide/metabolismo , Hormônios Tireóideos/análise , Hormônios Tireóideos/sangue , Tri-Iodotironina Reversa/sangueRESUMO
We measured maternal cortisol levels after the onset of labor. Blood from 82 primiparas and 48 multiparas were collected 124 times and 60 times, respectively. When duration of labor was within 3 hr, there were no differences in cortisol levels between the primiparous (n = 11, 50.4 +/- 7.0 micrograms/100 ml, mean +/- S.E.) and multiparous (n = 14, 37.8 +/- 4.3 micrograms/100 ml). However, when duration of labor was from 3 to 6 hr, cortisol levels in the primiparas (n = 20, 59.7 +/- 5.1 micrograms/100 ml) were significantly (p less than 0.05) higher than those in the multiparas (n = 22, 46.8 +/- 2.9 micrograms/100 ml). In cases of duration of labor from 6 to 9, cortisol level of the primiparas (n = 24, 64.3 +/- 4.4 micrograms/100 ml) were also significantly (p less than 0.05) higher than those in multiparas (n = 12, 49.4 +/- 4.7 micrograms/100 ml). When duration of labor was more than 9 hr there was no significant difference in cortisol level between the primiparas and multiparas. Maternal cortisol level had a significant (p less than 0.01) negative correlation (n = 166, r = -0.243, Y = -0.09X + 30.47) with unconjugated estriol level. These data suggest that maternal cortisol levels after the onset of labor are slightly different between the primiparous and multiparous, and that maternal unconjugated estriol levels decrease owing to reduction of the feto-placental blood circulation accompanied with uterus contraction during labor.
Assuntos
Hidrocortisona/sangue , Trabalho de Parto/sangue , Feminino , Humanos , Troca Materno-Fetal , Paridade , GravidezRESUMO
We measured maternal serum unconjugated estriol (SUE3) levels in 244 cases (218 cases with labor and 26 without labor) and investigated the relationships among several obstetrical factors and SUE3 levels. There was no significant difference in the SUE3 level between the group with labor and the group without labor. However, the SUE3 level decreased gradually with prolonged duration of labor in multipara. There were significant positive correlations between the SUE3 levels and birth weights (n = 82, r = 0.375, p less than 0.01) or placental weights (n = 82, r = 0.381, p less than 0.01) in the multipara with labor. The SUE3 levels of fetal distress cases (n = 30, 20.0 +/- 8.6 ng/ml) were significantly (p less than 0.05) lower than those without fetal distress (n = 188, 24.5 +/- 9.7 ng/ml). These data suggest that maternal SUE3 might have been affected with feto-placental function, even after the onset of labor SUE3 levels decrease with prolonged duration of labor.
Assuntos
Estriol/sangue , Trabalho de Parto/sangue , Cesárea , Feminino , Humanos , Tamanho do Órgão , Paridade , Placenta/anatomia & histologia , GravidezRESUMO
We measured beta-endorphin (beta-EP) and beta-lipotropin (beta-LPH) levels in human maternal and fetal plasma and amniotic fluid, simultaneously. It appeared evident that maternal circulating levels of beta-EP (n = 11, 163.9 +/- 12.9 pg/ml, mean +/- S.E.) and beta-LPH (n = 11, 413.0 +/- 25.9 pg/ml) at delivery were significantly (p less than 0.01) higher than those of maternal plasma at term (beta-EP; n = 4, 18.3 +/- 2.1 pg/ml, beta-LPH; 213.4 +/- 24.3 pg/ml) and those of amniotic fluid (beta-EP; n = 5, 8.5 +/- 1.2 pg/ml, beta-LPH; 215.1 +/- 44.9 pg/ml). Fetal beta-EP levels (n = 11, 79.1 +/- 5.8 pg/ml) were significantly (p less than 0.01) higher than those of amniotic fluid. These data suggest that the origin of amniotic fluid beta-EP may be an increased synthesis in the maternal and fetal pituitary gland but not in the placenta.
Assuntos
Líquido Amniótico/análise , Endorfinas/sangue , Sangue Fetal/análise , Trabalho de Parto , beta-Lipotropina/sangue , Feminino , Humanos , GravidezRESUMO
Between July 1, 1986 and January 31, 1988, genetic amniocentesis was performed on 205 patients. The maternal serum alpha-fetoprotein (AFP) and amniotic fluid AFP levels were measured by enzyme immunoassay. Gestational dates were confirmed by sonography, and AFP results were expressed as multiples of the median (MOM). The median of maternal serum AFP from 15 to 17 weeks of gestation was 43.4, 62.6 and 72.5 ng/ml. Three fetuses with chromosomal anomalies were diagnosed; trisomy 21, 4p trisomy, and trisomy 18 (trisomy 18 was in one fetus of a twin pregnancy; the other fetus was normal). Maternal serum AFP levels were, 0.41, 0.49 and 1.30 MOM. Maternal serum AFP less than 0.5 MOM in normal pregnancies was 1/205 (0.5%) and less than 0.6 MOM was 9/205 (4.4%). There was no relationship between maternal serum AFP and amniotic fluid AFP levels. Our results are in agreement with the majority of the results in the literature, showing that maternal serum AFP levels are lower in association with autosomal trisomy fetuses.
Assuntos
Aberrações Cromossômicas/diagnóstico , Diagnóstico Pré-Natal , alfa-Fetoproteínas/análise , Adulto , Amniocentese , Transtornos Cromossômicos , Feminino , Idade Gestacional , Humanos , Técnicas Imunoenzimáticas , GravidezRESUMO
We measured maternal venous (MV), umbilical arterial (UA), and umbilical venous (UV) cortisol levels of 180 pregnancies at term. The cortisol level of MV was higher than that of UA and UV in all deliveries. The cortisol levels of three samples had no difference between the induced labor group and the spontaneous onset of labor group regardless of delivery mode. In spontaneous vaginal delivery the cortisol levels of three individual samples were significantly higher in primipara than in multipara. The positive correlations were observed in any modes of deliveries between the cortisol levels of MV and UA, and MV and UA and UV. These data suggest that the fetus may produce cortisol by itself and maternal cortisol may inflow to the fetus.
Assuntos
Parto Obstétrico , Hidrocortisona/sangue , Artérias Umbilicais/metabolismo , Veias Umbilicais/metabolismo , Apresentação Pélvica , Cesárea , Feminino , Feto/metabolismo , Humanos , Hidrocortisona/biossíntese , Trabalho de Parto Induzido , Troca Materno-Fetal , Paridade , Gravidez , Vácuo-Extração , VeiasRESUMO
The changes in serum specific hCG and prolactin levels were studied in 20 women after the evacuation of normal pregnancy at 5-10 weeks (group A) and 10 patients after the evacuation of molar pregnancy of 9-16 weeks (group B). The elimination of circulating hCG was faster in group A than in group B, and that in women after term delivery(group C)was faster than in both groups A and B. The half-life of the serum hCG level was 44.4 hrs in group A, 42.7hrs in group B, and 38.9hrs in group C, respectively. The mean level of serum prolactin in group A was 27.4ng/ml at 0 day, 64.5ng/ml at 4-7 days, and 31.9ng/ml at 13-15 days after evacuation, respectively. The surge was statistically significant. Though no regular tendency was found in the prolactin levels in group B, the levels were relatively higher than in group A and nonpregnant women. No correlation was found between hCG and prolactin levels in either group A or group B. The administration of drugs, such as methotrexate, did not affect the prolactin levels. On BBT, the resumption of ovulation tended to occur when the prolactin level, rather than the hCG level, returned to its normal range.
PIP: The changes in serum specific human chorionic gonadotropin (hCG) and prolactin levels were studied in 20 women after the evacutaion of normal pregnancy at 5-10 weeks (group A) and 10 patients after evacuation of molar pregnancy of 9-16 weeks duration (group B). The elimination of circulating hCG was faster in group A than in group B; that in women after term delivery (group C) was faster than in either of the other groups. The 1/2-life of serum hCG levels was 44.4 hours in group A, 42.7 hours in group B, and 38.9 hours in group C. The mean level of serum prolactin in group A was 27.4 ng/ml at 0 days, 64.5 ng/ml at 4-7 days, and 31.9 ng/ml at 13-15 days after evacuation. The surge was statistically significant. Though no regular tendency was found in prolactin levels in group B, the levels were relatively higher than in group A and nonpregnant women. No correlation was found between hCG and prolactin levels in either A or B. The administration of drugs such as methotrexate did not affect prolactin levels. With regard to basal body temperature, the resumption of ovulation tended to occur when prolactin levels rather than hCG levels returned to the normal range. (author's modified)
Assuntos
Aborto Induzido , Mola Hidatiforme/sangue , Prolactina/sangue , Gonadotropina Coriônica/sangue , Feminino , Humanos , Ovulação , Período Pós-Operatório , GravidezRESUMO
Adrenocorticotropic hormone (ACTH), beta-lipotropin (beta-LPH) and beta-endorphin (beta-EP) were measured simultaneously in maternal plasma at delivery. Mean concentrations of beta-LPH and beta-EP in maternal plasma at delivery were significantly higher than those in normal control. There were significant positive correlations among ACTH, beta-LPH and beta-EP concentrations, respectively. These data suggest that beta-LPH and beta-EP were elevated during delivery and in parallel with each other.
Assuntos
Hormônio Adrenocorticotrópico/sangue , Endorfinas/sangue , Trabalho de Parto , beta-Lipotropina/sangue , Adulto , Feminino , Humanos , Paridade , Gravidez , beta-EndorfinaRESUMO
Serum testosterone (T) concentrations in 106 umbilical venous bloods and 104 neonatal venous bloods, which were obtained from preterm (32-36w) and term (36-41w) infants, were measured by RIA. Cord T levels of boys were higher in preterm infants than in term infants, and those of preterm infants were higher in boys than in girls. Neonatal T levels of girls decreased following delivery. But those of boys increased after 10 days of life. T levels were higher in boys than in girls at 11-30 days of life. Differences between preterm and term infants were not significant.